Covid-19 as another trigger for hbv reactivation: clinical case and review of literature

HIGHLIGHTS

• who: Caterina Sagnelli et al. from the Department of Mental Health and Public Medicine, Section of Infectious Diseases have published the paper: COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature, in the Journal: Pathogens 2022, 816 of 21/07/2022
• what: Data on the risk of HBV reactivation during COVID-19 are scarce, but those from other sectors (onco-haematological, rheumatological, gastroenterological) [36-51] strongly suggest that all patients, including SARS-CoV-2 RNA-positive, should be screened for markers of HBV infection before starting corticosteroid and / or immunosuppressive . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.